Sekisui Chemical (4204) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
2 Feb, 2026Executive summary
Q1 net sales reached ¥298.8 billion, up 4.7% year-over-year, with operating profit at ¥20.2 billion, up 32.1%, and ordinary profit at ¥26.5 billion; profit attributable to owners of parent was ¥23.7 billion, slightly down due to lower gains on investment securities.
All major segments except Housing saw increases in both net sales and operating profit; Housing segment improved profitability despite lower sales.
Record first-quarter operating and ordinary profits were achieved, driven by high value-added products, cost controls, and positive foreign exchange effects.
Financial highlights
Gross profit margin improved to 32.2% from 30.7% year-over-year; EBITDA for Q1 was ¥33.3 billion, up ¥5.5 billion.
Interim dividend per share to increase by ¥2 to ¥37; full-year dividend forecast at ¥75 per share.
Cash and deposits decreased by ¥31.2 billion to ¥107.4 billion; free cash flow for Q1 was negative at -¥17.7 billion.
Outlook and guidance
First-half FY2024 forecasts revised upward: net sales to ¥635.7 billion, operating profit to ¥44.8 billion, and profit attributable to owners of parent to ¥39.5 billion.
Full-year forecast maintained due to FX fluctuation risk: net sales ¥1,326.7 billion, operating profit ¥102.0 billion, and annual dividend of ¥75 per share.
Second quarter operating profit expected to slightly decline compared to plan and previous year due to raw material price impacts.
Latest events from Sekisui Chemical
- Record sales achieved, but profits fell on impairment and one-time costs.4204
Q3 20263 Feb 2026 - Record-high H1 sales and profit drive upward guidance and continued dividend growth.4204
Q2 202517 Jan 2026 - Record sales and profits achieved, with full-year profit and dividend forecasts raised.4204
Q3 20259 Jan 2026 - Record profits and sales achieved, with further gains and dividend growth targeted for FY 2025.4204
Q4 202524 Dec 2025 - Record sales and operating profit, but net income fell sharply on FX and investment losses.4204
Q1 202616 Nov 2025 - Record sales but lower profits and revised guidance amid weak auto and EV demand.4204
Q2 20261 Nov 2025